In Brief: Cancer supplements
Executive Summary
Cancer supplements: Oncologic Drugs Advisory Committee will discuss FDA draft guidances on clinical evidence of effectiveness for new cancer treatment uses of marketed drugs during afternoon of June 24 meeting...